Nephros Inc (NEPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2004 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 9,430 |
| Marketable Securities | 4,000 |
| Receivables | 20 |
| Inventories | 330 |
| Other current assets | 800 |
| TOTAL | $14,580 |
| Non-Current Assets | |
| Other Non-Current Assets | 4 |
| TOTAL | $4 |
| Total Assets | $15,420 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 1,200 |
| Accrued Expenses | 2,450 |
| Other current liabilities | 350 |
| TOTAL | $4,010 |
| Non-Current Liabilities | |
| TOTAL | $N/A |
| Total Liabilities | $4,010 |
| Shareholders' Equity | |
| Common Shares | 10 |
| Retained earnings | -39,750 |
| Other shareholders' equity | -2,320 |
| TOTAL | $11,400 |
| Total Liabilities And Equity | $15,410 |